Cyclo Therapeutics, Inc. Common Stock
CYTH
CYTH: Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company develops cyclodextrin-based products for the treatment of disease. Its drug candidate, Trappsol Cyclo, treats Niemann-Pick Type C disease (NPC). Its other products include Trappsol HPB, Trappsol Fine Chemical, and Aquaplex.
moreShow CYTH Financials
Recent trades of CYTH by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CYTH's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on CYTH's company Twitter account
Number of mentions of CYTH in WallStreetBets Daily Discussion
Recent insights relating to CYTH
Recent picks made for CYTH stock on CNBC
ETFs with the largest estimated holdings in CYTH
Flights by private jets registered to CYTH